Share on Facebook Share on Twitter Share on LinkedIn Share on Google+ Share by Email

Skip to content

Key resources

  • Bibliography
    Bibliography
  • Health promotion
    Health promotion
  • Health practice
    Health practice
  • Yarning places
    Yarning places
  • Programs
    Programs
  • Organisations
    Organisations
  • Conferences
    Conferences
  • Courses
    Courses
  • Funding
    Funding
  • Glossary
    Glossary
 

Hepatitis C treatment coming to Pharmaceutical Benefits Scheme (PBS)

Date posted: 9 March 2016

On 1 March 2016, drugs that have the potential to cure Hepatitis C, were listed on the Pharmaceutical Benefits Scheme (PBS). The PBS is a program of the Australian Government that provides subsidised prescription drugs to Australians.

In an ABC Radio National interview on 23 February 2016, Ms Helen Tyrrell, CEO of Hepatitis Australia, said that 'There have been few occasions in history where there is an opportunity to eliminate any disease. And by making these new hepatitis C medicines broadly available, it's setting Australia on a path to eliminate hepatitis C as a public health concern within a generation.'

Ms Tyrrell said that 'Anyone who has hepatitis C in Australia from 1 March will be eligible for these medicines, provided they are over 18 years of age. So we have done extremely well in Australia.'

For information regarding the PBS in Australia, please see the PBS website listed in the links below.

Sources: Hepatitis Australia, ABC Radio National (RN)

Links

 
Last updated: 14 March 2016
 
Return to top
 
spacing
 


Australia's National Research Centre on AOD Workforce Development National Drug and Alcohol Research Centre National Drug Research Institute